REFERENCES
- Hermosín M. C., Cornejo J., White J., Hem S. L. Sepiolite, a potential excipient for drugs subject to oxidativedegradation. J. Pharm. Sci. 1981; 70: 189–192
- Alvarez A. A. Singer, E. GalánSepiolite: properties and uses. Palygorskite-Sepiolite. Occurrences, Genesis and Uses, . Elsevier, Amsterdam 1984; 253–287
- Galán E. Properties and applications of palygorskite-sepiolite clays. Clay Miner. 1996; 31: 443–453
- Ortega-Huertas M., López-Galindo A., Palomo-Delgado I. Advances inClay Minerals. SEA, GranadaSpain 1996
- López-Galindo A., Torres-Ruiz J., González-López J. M. Mineral quantification in sepiolite-palygorskite de-posits usingX-ray diffraction and chemical data. Clay Miner. 1996; 31: 217–224
- European Pharmacopoeia (Spanish version). DGFPS, Madrid 1993; V.5.5.4.
- United States Pharmacopeia. 23rd ed., TheUnited States Pharmacopeial Convention, Rockville, MD 1995
- The National Formulary. 18th ed., The United StatesPharmacopeial Convention, Rockville, MD 1995
- Carr R. L. Evaluating flow properties of solids. Chem. Eng. 1965; 72: 69–72